- $9.62bn
- $10.04bn
- $2.71bn
Corrected: US court overturns Insulet's $59 mln insulin-pump trade secret verdict against EOFlow
Corrected: UPDATE 1-US court overturns Insulet's $59 mln insulin-pump trade secret verdict against EOFlow
US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow
U.S. STOCKS ON THE MOVE-Boston Scientific, Banc of California, Salesforce
U.S. STOCKS ON THE MOVE-UnitedHealth, Astrotech, Boston Scientific
Insulet falls after flagging defect in some insulin pods
U.S. STOCKS ON THE MOVEd-Micron, Abercrombie & Fitch, Q32 Bio
Insulet falls after flagging defect in some insulin pods
U.S. RESEARCH ROUNDUP- Agilent Technologies, Fedex, Synopsys
Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost
Brief: Insulet Initiates Voluntary Medical Device Correction For Certain Omnipod® Pods In The U.S. And Affected International Markets
U.S. RESEARCH ROUNDUP-ARM Holdings, CDW, Doordash
U.S. STOCKS ON THE MOVE-Instacart, New York Times, Novavax
U.S. STOCKS ON THE MOVE-DaVita, Knight-Swift, Madrigal Pharma
U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber
Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand
Insulet jumps after raising annual growth outlook
Insulet Q1 revenue rises 34%, beats estimates; lifts outlook
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines